4th Circ. Revives Chelsea Therapeutics Class Action

The Fourth Circuit dismantled a North Carolina federal court's ruling that dismissed allegations of misleading investors against Chelsea Therapeutics International Ltd. in a split decision on Monday, saying that the court...

Already a subscriber? Click here to view full article